stockrow
Friday 6 November 2026
Export PACS’s income statement to Excel — free account
PACS Group, Inc.
PACS Healthcare Medical Care Facilities
PACS Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 29.3% from fiscal 2024.
- Revenue
- +11.5%
- EPS
- +16.4%
- Free cash flow
- −4.31%
- Total debt
- +7.48%
Quarter to September 2026, against a year earlier
49.19
1.01
−2.01%
Follow PACS
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
23.69 | 25.08 | 20.72 | 31.47 |
+8 more quarters Free account |
P/S ratio |
1.15 | 1.21 | 0.93 | 1.13 | |
P/FCF ratio |
14.67 | 14.77 | 13.22 | 20.01 | |
P/Operating CF |
31.15 | 49.75 | 21.35 | (1,768.67) | |
P/B ratio |
5.40 | 6.04 | 4.84 | 6.30 | |
Price to Tangible BV |
6.16 | 6.44 | 5.18 | 6.78 | |
EV/Sales |
1.18 | 1.23 | 0.94 | 1.16 | |
EV/EBITDA |
13.46 | 14.17 | 11.42 | 16.69 | |
EV/Operating CF |
11.62 | 11.90 | 10.38 | 15.21 | |
EV/FCF |
15.02 | 14.95 | 13.34 | 20.52 | |
Quick Ratio |
0.73 | 0.84 | 0.91 | 0.90 | |
Current Ratio |
0.80 | 0.91 | 1.00 | 1.07 | |
Net Debt/EBITDA |
1.30 | 0.63 | 0.33 | 1.37 | |
Debt/Assets |
4.60% | 4.35% | 5.18% | 6.25% | |
Debt/Equity |
0.22 | 0.22 | 0.28 | 0.37 | |
Asset Turnover |
0.99 | 0.99 | 0.97 | 0.98 | |
Operating CF/Net income |
3.47 | 1.77 | 2.93 | (0.06) | |
Capex/Depreciation |
(1.56) | (1.27) | (1.16) | (3.11) | |
Interest Coverage |
19.56 | 18.10 | 18.69 | 11.04 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
9.24% | 8.00% | 7.91% | 8.36% | |
Intangible Assets out of Total Assets |
0.03 | 0.01 | 0.01 | 0.01 | |
Share Based Compensation of Revenue |
3.02% | 1.81% | 1.43% | 1.16% | |
Graham Net Nets |
(0.57) | (0.53) | (0.70) | (0.59) | |
Graham Number |
17.43 | 16.43 | 15.21 | 12.94 | |
Earnings Yield |
4.22% | 3.99% | 4.83% | 3.18% | |
Free Cash Flow Yield |
6.82% | 6.77% | 7.56% | 5.00% | |
Revenue per Share |
9.46 | 9.03 | 9.04 | 8.69 | |
Operating CF per Share |
1.33 | 0.86 | 1.50 | (0.02) | |
Capex per Share |
(0.21) | (0.17) | (0.14) | (0.32) | |
Free Cash Flow per Share |
1.13 | 0.69 | 1.37 | (0.34) | |
Cash per Share |
0.73 | 1.04 | 1.58 | 1.26 | |
Shareholders Equity per Share |
7.70 | 7.05 | 6.64 | 6.10 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
7.70 | 7.05 | 6.64 | 6.10 | |
Free Cash Flow |
178.74 | 108.98 | 214.51 | (53.75) | |
Working Capital |
(235.56) | (92.70) | (5.42) | 68.31 | |
Capital Expenditures |
(32.50) | (26.53) | (21.83) | (50.36) | |
Net Current Asset Value |
(3,752.73) | (3,578.57) | (3,553.22) | (3,561.85) | |
EV/EBIT |
15.90 | 16.63 | 13.34 | 19.86 | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.04 | |
Price to Operating Income |
15.53 | 16.43 | 13.23 | 19.37 | |
| Other line items | |||||
Average Receivables |
722.41 | 706.84 | 737.46 | 709.31 | |
Average Payables |
191.38 | 166.45 | 189.64 | 183.65 | |
Average Assets |
5,772.54 | 5,579.25 | 5,578.96 | 5,413.47 | |
Average Common Equity |
1,047.81 | 964.03 | 899.23 | 834.07 |
Columns are period end dates · fundamentals updated 5 Nov 2026